ZIVO Bioscience (NASDAQ:ZIVOW) Shares Down 12.5%
ZIVO Bioscience (NASDAQ:ZIVOW) Shares Down 12.5%
(Get Rating) Shares of ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating) fell 12.5% during trading on Friday . The stock traded as low as $0.60 and last traded at $0.63. 2,500 shares changed hands during mid-day trading, a decline of 42% from the average session volume of 4,339 shares. The stock had previously closed at $0.72.
ZIVO Bioscience, Inc.（納斯達克股票代碼：ZIVOW — 獲取評級）的股價在週五的交易中下跌了12.5％。該股的交易價格低至0.60美元，最後一次交易價格爲0.63美元。2500股在午盤交易中易手，較平均交易量4,339股下跌了42％。該股此前曾收於0.72美元。
ZIVO Bioscience Price Performance
ZIVO 生物科學性價比
The company has a 50 day moving average of $0.75 and a 200 day moving average of $0.74.
該公司的50天移動平均線爲0.75美元，200天移動平均線爲0.74美元。
Institutional Investors Weigh In On ZIVO Bioscience
機構投資者對 ZIVO Bioscience 進行權衡
An institutional investor recently raised its position in ZIVO Bioscience stock. Warberg Asset Management LLC grew its holdings in ZIVO Bioscience, Inc. (NASDAQ:ZIVOW – Get Rating) by 442.0% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 84,654 shares of the company's stock after acquiring an additional 69,034 shares during the quarter. Warberg Asset Management LLC's holdings in ZIVO Bioscience were worth $51,000 at the end of the most recent reporting period.
一位機構投資者最近提高了其在ZIVO Bioscience股票中的頭寸。根據美國證券交易委員會（SEC）的最新披露，華伯資產管理有限責任公司在第三季度將其在ZIVO Bioscience, Inc.（納斯達克股票代碼：ZIVOW — 獲取評級）的持股量增長了442.0％。該機構投資者在本季度又收購了69,034股股票後，擁有該公司84,654股股票。在最近的報告期末，華伯資產管理有限責任公司在ZIVO Bioscience的持股價值爲51,000美元。
ZIVO Bioscience Company Profile
ZIVO 生物科學公司簡介
(Get Rating)
（獲取評分）
ZIVO Bioscience, Inc is a Michigan-based biotech/agtech company dedicated to harnessing the immune health and nutritional benefits of bioactive compounds derived from its proprietary algal cultures. The development pipeline includes natural products for use as dietary supplements and functional food ingredients, as well as innovative, biologically derived and synthesized candidates designed to deliver medicinal and pharmaceutical benefits for humans and animals, with a specific focus on modulating the immune and inflammatory response.
ZIVO Bioscience, Inc是一家總部位於密歇根州的生物技術/農業科技公司，致力於利用其專有藻類培養物衍生的生物活性化合物的免疫健康和營養益處。該開發產品包括用作膳食補充劑和功能性食品原料的天然產品，以及旨在爲人類和動物提供藥用和藥物益處的創新、生物衍生和合成的候選產品，特別側重於調節免疫和炎症反應。
Featured Stories
精選故事
- Get a free copy of the StockNews.com research report on ZIVO Bioscience (ZIVOW)
- How to Invest in the Top Grocery Stocks for This Year
- Array Technologies Brings Solar Flare To 2023 Earnings Forecast
- Best Bank Stocks to Invest in Ahead of Rising Interest Rates
- How to Invest in Farmland: 7 Simple Ways
- ExxonMobil Gushes To New Highs
- 免費獲取 StockNews.com 關於 ZIVO Bioscience (ZIVOW) 的研究報告
- 如何投資今年最熱門的雜貨股
- Array Technologies將太陽耀斑帶入
- 在利率上升之前投資的最佳銀行股
- 如何投資農田：7 種簡單方法
- 埃克森美孚飆升至新高
Receive News & Ratings for ZIVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZIVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
接收《ZIVO 生物科學日報》的新聞和評級 -在下面輸入您的電子郵件地址，通過Marketbeat.com的免費每日電子郵件時事通訊接收ZIVO Bioscience及相關公司的最新新聞和分析師評級的簡明每日摘要。
譯文內容由第三人軟體翻譯。
